1009 |
Left Main PCI: Where We Are? Where We Are Going? |
Seung-Jung Park |
May. 12. 11 |
1008 |
Minimalist Approach: Physiologic Lesion Assessment Should Guide Routine PCI Therapy ! |
Nico Pijls |
May. 12. 11 |
1007 |
Stenosis, Physiology and Medications Are Not Enough: Vulnerable Plaque Must Be Identified |
Ik-Kyung Jang |
May. 12. 11 |
1006 |
Drug-eluting Balloons will Have an Important Role in Coronary and Peripheral Interventional Therapy |
Juan F. Granada |
May. 12. 11 |
1005 |
Will Bioabsorbable Stents Transform PCI in the Future? |
Patrick W. Serruys |
May. 12. 11 |
1004 |
Transcatheter Renal Denervation Therapy(TREND): A Breakthrough for Refractory Hypertension? |
Andrej Schmidt |
May. 12. 11 |
1003 |
Percutaneous LAA Closure: A Future Management Alternative for Stroke Prevention in AF Patients |
Horst Sievert |
May. 12. 11 |
1002 |
Is OCT Ready for ¡°Prime Time¡±: What¡¯s Known and What We Need to Know for Clinical Applications |
Gary S. Mintz |
May. 12. 11 |
1001 |
Beyond FAME: The Integration of Invasive Ischemia Assessment(FFR) into Clinical Practice |
William F. Fearon |
May. 12. 11 |
1000 |
DES in Left Main Disease: New Guidelines and Updates from EXCEL |
Gregg W. Stone |
May. 12. 11 |